secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001522767-23-000100
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q2 revenue $36.5M (+11% YoY); GAAP net loss $0.9M vs $1.9M profit
-------------------------------------------------------------------------

- Revenue $36.5M, up 11% from $33.0M year-over-year; wholesale set monthly and quarterly records.
- GAAP net loss $0.9M vs income $1.9M in Q2 2022; non-GAAP net income $0.6M vs $5.5M.
- Adjusted EBITDA $6.3M (17% margin) down from $8.9M (27% margin) last year; 14th straight positive quarter.
- Non-GAAP gross margin 46% flat YoY; balance sheet remains one of strongest in industry.
- Adult-use sales in Maryland commenced July 1, 2023, driving expected acceleration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000100/0001522767-23-000100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000100/mrmd-20230802.htm
  HTML page:      https://secwatch.observer/filing/0001522767-23-000100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer